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The human T lymphocyte antigen receptor (Ti)` is a disulphide-linked heter-
odimer composed ofan a and aa chain (1-3). This molecule is responsible for
the antigen specificity and MHC restriction of T cells, and participates in T
lymphocyte activation (4, 5). Ti molecules have been found at the surface of T
cells and some thymocytes (6). The genes that encode the human Ti. and Tip
molecules have been cloned and sequenced (7-11). A third homologous rear-
ranging gene, Ti,, has also been cloned; its role in T lymphocyte recognition of
antigen is unclear (12, 13).
Ti. and Ti# genes are remarkably similar to Ig genes. They consist of gene
segments that rearrange to form unique variable-region genes. As with Ig genes
in B cells, this rearrangement process occurs in an ordered fashion, and is
probably subject to allelic exclusion (14, 15). V, D, andJ segments participate in
the formation ofa complete Ti, 6 variable region gene (11, 16). In the human Ti.
gene, it is clear that V and J segments are involved in such rearrangements;
whether Da segments exist is still uncertain (9). The chief differences between
Ig and Ti genes are that only Ti genes encode molecules that must recognize
both antigen and MHC, and only Ig genes undergo somatic mutation.
Thymocytes and many T cell lines produce truncated Ti. and Tiq transcripts
that lack V regions, as well as full-length mRNAs. In mature peripheral T cells,
only full-length Ti. and Tio transcripts are synthesized (17-19). A similar
situation is seen in the B lymphocyte lineage, where pre-B cells and some B cell
lines express truncated Ig H chain transcripts (20-24). Some, but not all, ofthese
truncated Ig and Ti transcripts include D regions. In-frame translation initiation
codons are found upstream of some DH and Dg genes, and protein products
arising from truncated IgH transcripts have been observed (24, 25) in some
murine pre-B cell lines. The biological role oftruncated Ig and Ti transcripts
and their protein products is unclear. Others (26, 27) have proposed that
transcription of unrearranged Ig gene segments may mediate their increased
accessibility to "recombinases," orjoining enzymes.
It is intriguing that many human T cell lines, some of which have undergone
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DHJH rearrangements, express low levels of truncated IgH transcripts (20, 28).
We were interested in determining whether the converse situation exists, i.e.,
whether Ti genes are transcribed in B cells. In this study, we demonstrate that
truncated Ti. and Ti,p transcripts are indeed produced in small quantities in
human B cell lines, and in the case of Tis, in freshly purified tonsillar B cells.
However, rearrangements of Ti# genes in B cells are infrequent. These obser-
vations yield new insights into the relationship between Ti gene transcription
and rearrangement.
Materials and Methods
Cells.
￿
Cells were grown in suspension in RPMI 1640 medium supplemented with 10%
FCS, 50 U/ml penicillin G, and 50 jug/ml streptomycin . RPMI 4265 is a B cell leukemia
line obtained from Hugh McDevitt, Stanford University, Stanford, CA (29); Raji is a
Burkitt lymphoma cell line obtained from the American Type Culture Collection, Rock-
ville, MD (30); Josh-7 is a B cell precursor line from an X-linked agammaglobulinemia
patient, obtained from Shu Man Fu, The Rockefeller University, New York (31); RPMI
8226 is a X-secreting multiple myeloma cell line obtained from the American Type Culture
Collection (32); Jurkat is a T cell leukemia line obtained from Art Weiss, UCSF (33); HL-
60 and U-937 are promyelocytic leukemia cell lines obtained, respectively, from Robert
Gallo (National Institutes of Health, Bethesda, MD) and Hillel Koren, Duke University,
Durham, NC (34, 35); K562 is a leukemia cell line of the erythroid lineage obtained from
Y. W. Kan, UCSF (36); HeLa is a cervical carcinoma cell line obtained from the American
Type Culture Collection (37); and Colo-320 is a neuroendocrine tumor cell line obtained
from Manfred Schwab, UCSF (38).
Northern Blots.
￿
Poly(A) RNA was prepared from cell lines by SDS lysis, proteinase K
digestion, and oligo(dT) cellulose batch absorption (39) . For cell lines HL-60 and U-937,
due to high levels of endogenous ribonucleases, the guanidinium thiocyanate-cesium
chloride procedure was used for RNA extraction, followed by two rounds of oligo(dT)
cellulose chromatography (40, 41).
Poly(A) RNA was denatured in formamide and formaldehyde and electrophoresed
through 1 .2% formaldehyde-agarose gels, and blotted overnight to nitrocellulose paper
as described (41). Blots were baked in vacuo for 2 h at 80'C, then prehybridized and
hybridized to nick-translated probes under standard conditions (41). The Ti. probe was
the Eco RI insert of pY14, which contains the full-length Ti. cDNA from Jurkat (19).
The Tip probe was the Bam HI-Xba I insert of pT#F-neo, which contains the full-length
Tip cDNA from Jurkat (5). Hybridized blots were washed stringently; the final two washes
were 45 min each at 680C in 0.2x SSPE, 0.1% SDS. Blots were autoradiographed at
-70°C using preflashed Kodak XAR-5 film and Lightning-Plus intensifying screens
(DuPont Co., Wilmington, DE)
cDNA Cloning and Sequencing. Poly(A) RNA from the cell line RPMI 4265 was
prepared as described under Northern blotting, and used to construct a cDNA library in
the bacteriophage vector agt10 (42). The first-strand synthesis reaction contained 5 Ag of
RPMI 4265 poly(A) RNA, 4 ag of oligo(dT, 2_, S) (Collaborative Research, Lexington,
MA), 0.06 U RNAsin (Promega Biotech, Madison, WI), 60 U avian myeloblastosis virus
reverse transcriptase (Boehringer Mannheim Diagnostics, Houston, TX), 35 mM 2-ME,
640 gM of each dNTP, 5 uCi of each [12P]dNTP (800 Ci/mmol, Amersham Corp.,
Arlington Heights, IL), 100 mM Tris (pH 8 .3), 60 mM KCI, and 7 mM MgC12. RNA-
DNA duplexes were tailed with terminal transferase (P-L Biochemicals, Milwaukee, WI)
and dGTP, and second-strand cDNA synthesis was primed with oligo(dC, 2_, 8) (Collabo-
rative Research) as described (42); since 3' recessed ends are not tailed under these
conditions, full-length first strands are preferentially primed for second-strand synthesis .
After second-strand synthesis with DNA polymerase I, the pH was adjusted to 8 .3, KCl
and 2-ME were added to 60 mM and 30 mM, respectively, and 20 U of reverse
transcriptase were added to finish elongation of second strands stalled at polymerase I1942
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pause sites. After protection of cDNA Eco RI sites with Eco RI methylase (New England
Biolabs, Beverly, MA) and S-adenosylmethionine, and purification of double-stranded
cDNA on Sephadex G-50, a final elongation step was performed with DNA polymerase I
to finish any incomplete syntheses and to generate blunt ends for ligation to Eco RI
linkers. After linker addition and Eco RI digestion, double-stranded cDNA longer than
800 by was isolated by preparative agarose gel electrophoresis and electroelution. The
cDNA was ligated to \gt10 arms, packaged in vitro, and amplified on Escherichia coli
strain C600 hfl, as described (42).
The library was screened with nick-translated Ti. and Tis probes by standard techniques
(41). Positive clones were plaque purified, and inserts were subcloned into Eco RI-
digested M13 mp8 (43). 12P and s5S sequencing by the dideoxy method were performed
essentially as described (44). Primers used were the M13 universal sequencing primer
(Pharmacia Fine Chemicals, Piscataway, NJ), and internal 20-nucleotide primers comple-
mentary to the C., and Co genes near the J-C junctions (nucleotides 622-641 of pY14,
and nucleotides 488-507 of YT35 ; references 7, 19).
Southern Blotting. Genomic DNA samples from various cell lines were prepared by
lysis of washed cells with sarcosyl and proteinase K as described under Northern Blots,
followed by extraction with phenol and precipitation with ethanol. DNA samples were
digested with Eco RI, electrophoresed on a 0.7% agarose gel, and transferred to a nylon
membrane (41). After crosslinking of the DNA to the membrane by UV irradiation (45),
the blot was probed with a 32P-labeled, 4.0-kb genomic Eco RI fragment containing the
human C02 gene and a 4.1-kb genomic Eco RI fragment containing the humanJ#2 gene
cluster (11). The blot was washed stringently and autoradiographed by standard proce-
dures(41).
Preparation and Analysis of Tonsillar T and B Cells.
￿
Lymphocytes were removed from
a non-neoplastic adult human tonsil by perfusion and were purified by Ficoll-Hypaque
centrifugation. Adherent cells were removed by incubation at 37°C for 45 min in plastic
dishes. T and B cells were separated by nylon-wool chromatography (46). The B cell
fraction was further purified by rosetting out contaminating T cells with 2-S-amino-
ethylisothiouronium bromide (AET)-conjugated SRBC . Aliquots (2 X 106 cells) of T and
B cell fractions were washed and stained with FITC-conjugated rabbit anti-human Ig or
FITC-conjugated OKTI I (Ortho Diagnostic Systems Inc., Westwood, MA); fluorescence
was determined by flow microfluorimetry on a FACS IV (Becton Dickinson Immunocy-
tometry Systems, Mountain View, CA). From the remainder of the cells, poly(A) RNA
was isolated as described under Northern Blotting. T and B cell RNA samples were
electrophoresed on a 1 .0% formaldehyde-agarose gel, blotted to nylon membrane, cross-
linked to the membrane by UV irradiation (45), prehybridized, and hybridized to "P-
labeled Ti and Tio probes, then were washed stringently and autoradiographed (41).
Results
Detection of Truncated Ti Transcripts in B Cell Lines.
￿
Poly(A) RNA was pre-
pared from four human B cell lines to examine their production of Ti. and Tip
mRNA . The cell lines were chosen to represent a wide variety of B cell pheno-
types, including Burkitt's lymphoma (Raji), lymphocytic leukemia (RPMI 4265),
Iga-secreting myeloma (RPMI 8226), and a B cell line from an X-linked agam-
maglobulinemia patient (Josh-7) (29-32). By Southern and Northern blotting,
we verified that all four cell lines were clonal, had rearranged their IgH and IgK
genes, and expressed Iga mRNA (data not shown) . Poly(A) mRNA was also
prepared from the T cell line Jurkat, the myeloid lines HL-60 and U-937, and
the neuroendocrine cell line Colo-320 (33-35, 38). RNA samples were electro-
phoresed through formaldehyde-agarose gels, blotted to nitrocellulose, hybrid-
ized to ;2P-labeled Ti. and Ti, 3 cDNA probes, and washed at high stringency.
With the Tin probe, Jurkat showed abundant levels of the expected 1 .7-kb Ti~CALMAN AND PETERLIN
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FIGURE 1 .
￿
Northern blot analysis of Ti gene expression in human cell lines . Poly(A) RNAs
from various cell lines were analyzed by Northern blotting. Lane 1, jurkat ; lane 2, RPMI
4265 ; lane 3, Raji ; lane 4, josh-7 ; lane 5, RPMI 8226 ; lane 6, Colo-320 ; lane 7, HL-60 ; lane
8, U-937 . Lane 1 contains 1 .4 wg ofRNA; all other lanes contain 5 jug . (A) Ti . probe, (B) Tig
probe . Autoradiography exposure times : lanes 1-6, 24 h ; lanes 7-8, 72 h .
mRNA, as shown in Fig . IA . In contrast, the B cell lines josh-7 and RPMI 4265
contained low levels of truncated 1 .3-kb Ti. transcripts . By densitometry, josh-
7 and RPMI 4265 contained 15% and 4%, respectively, of the amount of Ti.
mRNA seen in jurkat . Raji and RPMI 8226 displayed no detectable Ti. mRNA
even after prolonged exposure . U-937 and Colo-320 were also totally negative
for Ti. transcripts, whereas the myeloid cell line HL-60 showed barely detectable
levels of 1 .3- and 1 .4-kb Ti.mRNA ; this represented <1/200 of the levels seen
in the T cell line . Failure to detect Ti. mRNA in Colo-320 and some of the B
cell lines was not due to RNA degradation or failure of the RNA to transfer to
nitrocellulose, since actin mRNA was detected in all lanes when the blot was
rehybridized with a -y-actin cDNA probe (data not shown) .
When Northern blots were probed at high stringency with the full-length Ti '3
cDNA probe, as seen in Fig . 1 B, the T cell linejurkat showedabundant quantities
of the full-length 1 .3-kb mRNA and smaller quantities of the truncated 1 .0-kb
mRNA, as well as small amounts of high molecular weight RNA which may
represent unspliced precursors . The B cell lines RPMI 4265, Raji, Josh-7, and
RPMI 8226 all expressed low levels of 1 .0-1 .1-kb truncated Tio transcripts . By
densitometry, the truncated Ti, 3 transcripts in these B cell lines were 2-5% as
abundant as the full-length transcripts in theT cell line jurkat . Colo-320 and U-
937 completely lacked Tio transcripts, while HL-60 expressed extremely low
levels of 1 .1-kb Tiq transcripts .
When similar Northern blots were probed with the Tio probe at lower hybrid-
ization stringency, no additional RNA bands were seen in any of the cell lines
(data not shown) . In preliminary experiments using a human Ti, cDNA probe,
we did not detect Ti .,, mRNA in any of the B cells used in this study (data not
shown) .
Sequence of Truncated Ti Transcripts in B Cells .
￿
We determined the structure
of Ti, and Ti, 3 transcripts in the B cell line RPMI 4265 by cDNA cloning and1944
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nucleotide sequencing. cDNA was constructed from RPMI 4265 mRNA and
inserted into the bacteriophage vector Xgt10. Special efforts were made to ensure
that the majority of clones were full length or nearly full length: after first-strand
synthesis, the cDNA was tailed with dGTP using terminal transferase under
conditions where only full-length first strands are tailed; the second strand was
synthesized sequentially by DNA polymerase I and reverse transcriptase, using
oligo(dC) as a primer; and cDNAs smaller than 800 by were removed by
preparative gel electrophoresis before insertion into the vector.
The RPMI 4265 cDNA library was screened with Ti. and Ti, 3 probes. ^-1
clone in 2,000 hybridized to the Ti. probe, and 1 in 10,000 to the Ti# probe.
Individual clones were isolated and subcloned into M13 mp8. The 5' and 3'
ends of these cDNA clones were sequenced by the dideoxy method, using the
M 13 universal primer and a synthetic oligonucleotide primer complementary to
the 5' region of Ca or Cp. The lengths of these cDNA clones agreed with those
of the corresponding mRNAs to within 100 nucleotides; thus, these are full-
length or nearly full-length cDNA clones.
The DNA sequences of five independent Ti. cDNA clones, all from the B cell
line RPMI 4265, are shown in Fig. 2. All of them have a similar structure,
consisting of 5' noncoding RNA, a heptamer-nanomer recombination sequence
(47), a J segment, and a C segment. Each uses a differentJ. segment, containing
19-21 codons. The putative amino acids that would be encoded by each of these
Jn segments (if appropriate translation initiation codons existed [48]) are shown
in Fig. 3. They show good homology to each other, and to aJa gene previously
identified in a T cell cDNA clone (8), particularly at the invariant residues F-G-
X-G seen in all Ti and Ig J segments. However, none of these five Ti. cDNA
clones can be translated in the correct reading frame. Clones R.2, R.3, and R.5
have AUG initiation codons in the 5'-flanking DNA or Ja segments, but all are
in incorrect reading frames, and all are followed by a translation stop codon
within 3-28 amino acids. For clones Rat and Ra4, the first AUG codon occurs
with the Ca region. This codon is also out of frame, and is followed by a
translation termination codon 17 amino acids downstream (8). Thus, the only
peptides that might be produced by translation of these truncated transcripts are
out of frame and very short, and are not likely to have any function. While the
genomic sequences surrounding these Ja genes are not yet known, the sizes and
sequences of these five clones strongly suggest that they are transcribed from
promoters upstream of unrearranged Ja genes.
Two Tip cDNA clones from RPMI 4265 were sequenced. As shown in Fig. 2,
clone R,31 contains the J#2.s and C#2 segments (11) . Clone R, 32, interestingly,
contains two differentJ0 segments. Both J,a2.4 and J,32,5 are present in this cDNA.
The RNA splice donor site at the 3' end of J,82.4 is not used; instead, the Ja2.5
splice donor site is spliced to C, 32 (11). Comparison with the known genomic
sequence of this region demonstrates conclusively that these Ti'3 cDNAs are the
productofunrearranged genes(11) . Neither oftheseclones contains atranslation
initiation codon in the 5'-flanking orJR regions. The first AUG codon lies in the
Cpl gene; it is in an incorrect reading frame and is followed by a stop codon 28
amino acids downstream (11). Thus, these transcripts do not encode Ti proteins.
Comparison of Tia cDNA Sequences from T and B Cells: Evidence for DaCALMAN AND PETERLIN
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FIGURE 2 . DNA sequences of Ti. and Ti y cDNA clones from B cell line RPMI 4265 .
Nucleotides derivedfromJgenes are in unshaded boxes. C genes are in shaded boxes . Heptamer-
nanomer joining sequences are heavily underlined. Nucleotides from J,e4., in clone Rs2 are
lightly underlined . The top five are Ti . cDNA clones ; the bottom two are TiscDNA clones .
Genes .
￿
While it is clear that Ti. transcripts in B cells contain only J and C
segments, it is likely that Da segments or non-germline-encoded N regions
contribute to the formation of full-length Ti. transcripts inT cells . This inference
is based on the comparison of the DNA sequence of a single Ti. cDNA clone
with its corresponding genomic Va and Ja sequences (9, 19) . In this study we
have been able to extend this conclusion . Since the B cell Ti. transcripts have
heptamer-nanomer recombination signals at the 5' ends of their Ja segments,
they almost certainly arise from unrearranged genes . Thus, their sequences can
be compared with the sequences of full-length transcripts in T cells to determine1946
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FIGURE 3 . Comparison of hypothetical Ti. translated protein sequences . Sequences are
shownfor the five RPMI 4265 Ti. cDNA clones and for theT cell line HPB-MLT . Conserved
amino acids are in shaded boxes . Small shaded boxes show the positions of heptamer-nanomer
recombination signals .
FIGURE 4 .
￿
Comparison ofTi.cDNA sequences from T andB cells . The region near the V-
J junction is shown for human peripheral T cell cDNA clones HAP 01 and HAP 02, and for
RPMI 4265 cDNA clones R.4 and R.I . Nucleotides from V., genes are lightly shaded ; Co
nucleotides are heavily shaded . Unshaded nucleotides are derived from either D. genes or N
regions .
which nucleotides in the T cell cDNAs were derived fromJ. segments . Similarly,
comparison of full-length cDNAs from different T cell lines that use the same
V. gene but differentJa genes can reveal which nucleotides were contributed by
Va segments . Nucleotides that were not derived from Va or Ja genes must have
been contributed either by Da genes or by N regionsadded by terminal transfer-
ase .
Yoshikai et al . (49) recently sequenced 24 different Ti. cDNA clones from
human peripheral T lymphocytes. Two of these T cell cDNAs use the same Ja
segments as two of our B cell cDNAs. The B cell clone Ra l uses the same J.
segment as the T cell clone HAP02, as seen in Fig. 4 . HAP02 and another T
cell cDNA clone, HAP29, use the same Va but different Ja segments ; thus, the
3' boundary of the Va segment can be precisely determined .
HAP02 contains 14 nucleotides that are not accounted for by Va or
Ja
segments . These nucleotides must be derived from either a Da gene or an N
region added by terminal transferase (50) . Similarly, the T cell cDNA clone
HAPO1 uses the same Jsegment as the B cell cDNA clone R.4 (49), and the 3'
boundary of its V region can be determined to within three nucleotides by
analogy to other T cell Ti. cDNA clones . As seen in Fig . 4, HAPO1 contains 13
± 3 nucleotides derived from either a Da gene or nongermline elements .
Lack of Rearrangement of Tis Genes in B Cell Lines.
￿
Because the
J. segments
are spread out over >50 kb of genomic DNA, it is impossible to study Ti. gene
rearrangements by ordinary Southern blotting using C. probes (9) . However,CALMAN AND PETERLIN
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FIGURE 5 .
￿
Southern blot analysis ofTiqgene rearrangements . (A) restriction mapof human
Tio genes . Positions of Eco RI restriction sites are indicated by arrows labeled "R". Sizes of
relevant Eco RI restriction fragments, in kilobase pairs, are shown . Shaded boxes indicate the
locations of the J#2andCe2probes . The region ofCs , that crosshybridizes with the Cat probe
is indicated by abox outlined with dashed lines . (B) Southern blot . 10 Eg ofDNA from various
cell lines were electrophoresed on a 0.8% agarose gel, blotted to nylon paper, hybridized with
s2P-labeled Jag and C#2 probes, and autoradiographed . Lane 1, HeLa ; lane 2, Colo-320 ; lane
3, HL-60 ; lane 4, U-937 ; lane 5, K562 ; lane 6, Jurkat ; lane 7, josh-7 ; lane 8, Raji ; lane 9,
RPMI 4265 ; lane 10, RPMI 8226 . Autoradiography exposure wasfor 96 h .
the Tit , genes can be studied by this technique . By digesting genomic DNA from
various cell lines with the restriction enzyme Eco RI, and probing Southern blots
of this DNA with a combination of Ct , and Jt, genomic probes, it is possible to
detect all rearrangements involving either theJ31 or J,32 gene cluster (Figure 5A)
(11) . In Fig . 5B, such a Southern blot is shown, using DNA from the four B cell
and plasma cell lines, the T cell line Jurkat, and five myeloid and nonhemato-
poietic cell lines . Only the T cell line displayed bands of altered mobility,
indicating rearrangement of its Tit , genes . All of theB cell and nonlymphoid cell
lines displayed the germline pattern of DNA bands. These data confirmed the1948
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FIGURE 6 . Ti expression in human tonsilar lymphocytes . (A) FACS analysis of purified
tonsilar T and B cells . Solid lines, cells stained with anti-1g; dotted line, cells stained with
OKT11 . Fluorescence intensity is plotted on the abscissa on a logarithmic scale; relative cell
number is plotted on the ordinate . (B) Northern blot analysis . mRNA was prepared from the
same tonsilar T and B cell populations used in A. 500 ng samples of poly(A) RNA were
analyzed by Northern blotting . Left, Ti~ probe . Right, Tip probe . T, mRNA from purified T
cells ; B, mRNA from purified B cells . Autoradiography exposure times, 16 h for T ; 48 h for
B.
conclusion, from sequencing of cDNA clones, that the Ti, 3 genes were not
rearranged in theseB cell lines .
Truncated Ti Transcripts in TonsillarB Cells.
￿
Finally, we sought to determine
whether expression of low levels of truncated Ti. and Ti# transcripts in human
B cell lines represented a bona fide physiological phenomenon, or was merely an
artifact of in vitro cell culture . We purified lymphocytes from a non-neoplastic
adult tonsil, and fractionated T andB cells by nylon-wool chromatography . The
B cell fraction was depleted of any residualT cellsby rosetting with AET-treated
SRBC . Aliquots of theT andB cell fractions were stained with FITC-conjugated
rabbit anti-human Ig and OKT11, and examined by flow microfluorimetry ;
from the remainder of the cells, poly(A) RNA was purified . The right half of
Fig . 6A shows theFACS analysis of the purified B cells; >99% of the cells were
OKT11- and surface Ig+ . Thus, these tonsillar B cells were essentially free of
contaminating T cells and nonlymphoid cells . In the left half of Fig . 6A, in
contrast, ^-85% of the purifiedT cells were OKT11+ and 90% were surface Ig ,
suggesting that theT cells were slightly contaminated with B cells and nonlym-
phoid cells .
Poly(A) mRNA from the purified tonsillarT and B lymphocytes was analyzed
by Northern blotting using Ti. and Ti# probes . As seen in Fig. 6B, the T cells
contained abundant full-length, 1 .7-kb Ti. transcripts ; no Ti. mRNA was seen
in the B cells. In contrast, low levels of truncated Tip transcripts of 1.0-1 .1 kb
were clearly seen in the purified B cells, while the T cells expressed abundantCALMAN AND PETERLIN
￿
1949
1 .3-kb transcripts and lower levels of truncated 1 .0-kb transcripts. No clear 1.3-
kb band was seen in the B cell lane; this is further evidence that the B cell
preparation was not contaminated with T cells. Thus, truncated Tip transcripts,
but not Ti. transcripts, are expressed in tonsillar B cells.
Discussion
We have examined the expression of truncated mRNA transcripts ofTi. and
Tip genes in human B cells. Such transcripts are present at low levels in several
B cell lines examined and, in the case of Tip, in tonsillar B cells. These transcripts
arise from unrearranged genes, and do not encode Ti proteins. The fact that
expression of these truncated transcripts is lymphocyte specific, and probably
occurs from multiple, coordinately regulated promoters upstream ofdifferent J
segments, suggests that the transcripts have some conserved function. Since this
function is not mediated by a protein product, this transcription may itself play
a role in lymphocyte function or development. Based on data from studies (26,
27) of Ig gene rearrangement, it is probable that transcription is involved in the
process that renders Ti gene segments accessible to the enzymes that mediate
rearrangement . This hypothesis is consistent with the fact that both the abun-
dance of Tip transcripts, and the frequency of Tip gene rearrangements, are
highest in Tcells, intermediate in B cells (and some myeloid cells), and absent in
nonhematopoietic cells (51, 52).
Tip Transcripts are Found in Human B Cells.
￿
We used Northern blot analysis
to test for the presence of Ti. and Tip poly(A) mRNA. We detected low-
abundance, 1.0-1 .1-kb Tip truncated transcripts in all four human B cell lines
examined, representing developmental stages from immature B cells to Ig-
secreting plasma cells (26-29). Such transcripts are present at an abundance of
roughly 1-5 copies per cell, based on the frequency of positive clones obtained
in screening the RPMI 4265 cDNA library, and considering the cloning bias in
favor ofRNA species shorter than 2 kb in the Xgt10 system. The low abundance
of these transcripts (up to 50-fold less abundant in B cell lines than in T cell
lines) explains why they have not been previously detected; indeed, we could
detect them only after using relatively large amounts of poly(A)-enriched RNA
and highly radioactive DNA probes. The Tip mRNA bands seen in the B cell
lines are somewhat broad. We attribute this to heterogeneity in the population
of truncated transcripts. Multiple Jp promoters give rise to transcripts having
different 5' ends and slightly different lengths. Extremely low levels of 1 .1-kb
Tip transcripts, roughly an order of magnitude less abundant than in the B cell
lines, were also detected in one oftwo myeloid leukemia lines studied.
Truncated Ti. Transcripts are Found in Some B Cell Lines. Truncated Ti.
transcripts were detected in two of the four B cell lines, and were not seen in
tonsillar B cells. The presence of truncated Ti. transcripts in some but not all
human B cell lines has also been noted by others (19). We estimate that the B
cell lines RPMI 4265 andjosh-7 contain 10-20 copies of Ti. mRNA per cell. It
is not clear why some ofthe B cell lines synthesize truncated Ti. transcripts while
others do not. Since josh-7, which has cell surface markers characteristic of
immature B cells, expresses Ti. transcripts, while the fully differentiated plasma
cell line RPMI 8226 does not, Ti. transcription may be confined to early stages1950
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of B cell development. A more comprehensive survey of B cell lines in various
stages of development would be needed to resolve this question . One of two
myeloid leukemia lines studied expressed 1.3- and 1.4-kb Ti. transcripts, at a
level at least an order of magnitude lower than that seen in the two B cell lines.
It is striking that multiple Ja promoters, spread over more than 50 kb of
genomic DNA, appear to be coordinately regulated. In the B cell line RPMI
4265, at leastfive differentj, genes, andprobably many more, aresimultaneously
transcribed. In contrast, two other B cell lines contain no detectable Ti. tran-
scripts. This strongly suggests that these multiple Ja promoters are switched on
and off in concert, in response to specific positive and/or negative transcription
factors, in a tissue- and stage-specific manner. The precise start site of transcrip-
tion, and the location of regulatory elements involved in Ti transcriptional
control, are not known. In Ig H chainj genes, where similar truncated transcripts
are seen, multiple transcription initiation sites are involved (53).
Structure of Ti Transcripts in B Cells.
￿
We sequenced several representative Ti.
and Tij3 cDNA clones from RPMI 4265 to determine their structures and
potential protein coding domains. Of the five Ti. and two Tig cDNA clones
sequenced, all are apparently transcribed from promoters upstream of Ja or J3
genes, and contain J and C coding segments. In each case, the J segment is
flanked at its 5' end by a heptamer-nanomer recombination signal (47) . All of
these cDNAs are transcribed from unrearranged genes (though this cannot be
formally proven for the Ti. genes until the genomic sequences of these Ja genes
are known), and cannot encode Ti proteins, since no in-frame AUG codons are
present. We cannot exclude thepossibility that other truncated transcripts, which
were not sequenced in this study and which use different J segments, may be
translated to yield truncated Ti proteins.
The inability of truncated J-C transcripts from Ti. and Ti# genes to be
translated has precedents in other Ti and Ig systems. Truncated C and J-C,, H
chain Ig transcripts from B cells are also generally "sterile," or incapable of
encoding protein, as are some truncated C and Ti# transcripts in T cells (54-
56). Some of the DJ-CH transcripts seen in Abelson-transformed pre-B cells are
translated (22). The functional role of such "D," proteins is unknown, though
they appear to be glycosylated and inserted into the endoplasmic reticulum (22).
Da Segments ofN Regions Contribute to Ti. Gene Formation in T Cells.
￿
Evidence
for Da genes or N regions in the human Ti. gene complex has been scanty and
inferential, based on the comparison of genomic and cDNA sequences for a
single cell line, Jurkat (9, 19). We have extended this observation by comparing
Ti. cDNA sequences from T and B cells. By comparing sequences from full-
length T cell transcripts and truncated B cell transcripts that use the same Ja
gene, one can delineate precisely which nucleotides in the T cell transcripts were
derived from Ja genes. Similarly, by comparing the sequence of different T cell
transcripts which use the same Va but different Ja genes, one can determine
which nucleotides were derived from Va genes.
In the two cases where we were able to make such comparisons between our
truncated B cell transcripts and the T cell Ti. transcripts described by Yoshikai
et al. (49), we found that 13-14 nucleotides of the full-length T cell transcripts
were not contributed by either Va or Ja genes. Therefore, by analogy with Ti#CALMAN AND PETERLIN
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and Ig H chain genes, these 13-14 nucleotides must be derived either from Da
genes or from non-germline-encoded elements (N regions) thought to be added
by terminal transferase during the rearrangement process (50). The length of
13-14 nucleotides corresponds closely to the length of known D# and DH genes
(16, 28), whereas most N regions are considerably shorter. Proof that those
nucleotides are derived from Da genes will require the cloning of genomic Da
genes.
Low Frequency of Rearrangement of Ti Genes in B Cells.
￿
For the Ti, 3 genes,
analysis of gene rearrangement is readily accomplished by standard Southern
blotting (14, 51, 52). Using a combination of DNA probes that can detect any
rearrangement involving either theJ#, or J#2 cluster, we found that the four B
cell lines and five myeloid and nonhematopoietic cell lines examined had all
retained their Ti, 3 genes in the germline configuration.
While none of the B cell lines in our small survey had undergone Tig gene
rearrangements, larger studies performed by others (51, 52) suggest that such
rearrangementsdo occuroccasionally. In one such series, 5 of33 B cell leukemias
and lymphomas had undergone Ti,e rearrangements (51). The precise nature of
these rearrangements was not determined, but they may have included Drjo
rearrangements and, in a few cases, more complex rearrangements. In another
study, 39 non-T, non-B acute lymphoblastic leukemias were examined for Ig
and Ti gene rearrangements (52). All had undergone Ig Hchain gene rearrange-
ments; of these, 10 of 39 had also rearranged or deleted their Ti, 3 genes. The
frequencies of Ti# rearrangement observed in these B cell tumors (15%) and
presumptive lymphocyte precursors (26%) resemble the frequency of the con-
verse event, i. e., D-j rearrangement of Ig H chain genes in T cells (20, 28, 51).
T or B lymphocytes that have rearranged both Ig and Ti genes nevertheless
retain a "pure" T or B phenotype, as determined by lineage-specific cell surface
antigen expression (51). Thus, occasional rearrangement of an inappropriate
antigen receptor gene is unlikely to have functional consequences. Finally, it is
notable that in a survey of myeloid tumors, only 3 of 24 (12%) were found to
have undergone Tio gene rearrangements (57). These three tumors expressed
Ti, 3 transcripts.
Analysis of Ti. gene rearrangements is complicated by the great genomic
distance between the Ca gene and most of the Ja genes. Standard Southern
blotting using Ca probes is generally uninformative. We attempted to analyze
Ti. rearrangements usingoligonucleotide probes complementary to three differ-
ent Ja segments, based on the sequence of the RPMI 4265 Ti. cDNA clones.
When these probes were hybridized to Southern blots of DNA from various cell
lines, multiple bands were detected even at relatively high hybridization strin-
gencies, indicating that the cloned Ja segments were members of families of
closely related Ja genes (data not shown). While minor differences in band
patterns were noted between different cell lines, it was impossible to ascertain
whether they represented rearrangements or merely DNA polymorphisms, es-
pecially since a restriction fragment length polymorphism linked to the human
Ca gene has already been reported (58). Reliable analysis ofTi. gene rearrange-
ments in B cells will require Southern blotting ofDNA electrophoresed on pulse-
field gels (59). In any case, the sequencing of five Ti, cDNA clones from RPMI1952
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4265 has shown that most, and probably all, ofthe truncated Ti. transcripts in
this B cell line arise from unrearranged genes.
Relationship Between Transcription and Rearrangement of Antigen Receptor
Genes. Transcription of unrearranged antigen receptor gene segments is a
widespread phenomenon. Truncated Ig H chain transcripts have been noted in
many B cells and some T cells. These transcripts consist ofJH-C, RNA from
unrearranged IgH genes, as well as DHJH-C,. transcripts from genes that have
undergone DHJH rearrangement but not VH-DJH rearrangement (20-24). Simi-
lar truncated transcripts have been detected from Ti. and Tip genes in T cells,
thymocytes and, in the present study, B cells (17-19, 60). In particular, 1.0-kb
truncated Tip transcripts, but not full-length transcripts, are detected in day-14
murine thymocytes (60). At this stage, the majority of thymocytes' Tip genes
retain the germline configuration, while a few have undergone DrJo rearrange-
ment (60). Unrearranged VH genes are transcribed in Abelson-transformed B
cell precursors that are in the process of undergoing VH-DJH rearrangement
(26). Recently, Ig C region genes were shown to be transcriptionally active in B
cells undergoing Ig class switching (27, 61). Thus, transcription ofgene segments
before their rearrangement appears to be a common theme.
Others (26, 27) have proposed a model that relates the phenomena ofantigen
receptor gene transcription and rearrangement . They suggested that rearrange-
ment ofreceptor gene segments requires not only that a recombinase be present,
but also that the chromatin surrounding the gene in question be "accessible" to
this enzyme. This accessibility is accompanied by transcription, and is demon-
strable by increased sensitivity ofthe affected regions to chemical and enzymatic
probes of chromatin structure, such as DNase I (27). Transcription could either
play a causative role in forming a more open chromatin structure, or it could
simply be a secondary manifestation of increased accessibility caused by some
otherprimary mechanisms. The mechanismsby which such changesin chromatin
structure might be brought about are not understood.
The accessibility model is supported by the observation that while recombi-
nation between endogenous Dp andJp genes occurs at extremely low frequency
in Abelson-transformed murine B cells, rearrangement between Dp and JO gene
introduced by DNA transfection occurs quite frequently (62). The frequency of
such D,3-J,3 rearrangement is similar to that oftransfected DHJH constructs. Thus,
the low frequency of endogenous Tip gene rearrangement in Abelson-trans-
formed murine lymphocytes cannot be due to an inherent inability of the
recombinase to catalyze this reaction, but rather must be due to some property
of the endogenous Tip genes or their surrounding chromatin, such as a "closed"
chromatin structure that is inaccessible to the enzyme. A more direct validation
of the accessibility model has come from recent studies by Alt et al. (27), where
high-frequency rearrangement of stably integrated transfected genes occurred
only when local transcriptional activity was high, and surrounding chromatin
was DNase-sensitive.
Our data indicate that low-level transcription from Jp promoters occurs in
human B cells and in some myeloid cell lines. Such transcription is accompanied
by rearrangement only about one-fifth ofthe time (51, 52). Thus, transcriptional
levels and rearrangement frequencies are roughly correlated . High levels ofCALMAN AND PETERLIN
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truncated Tis transcripts occur in thymocytes, which rearrange Tiq genes with
high frequency; low levels are found in human B cells, which rearrange much
less frequently; some myeloid lines have still lower levels of transcription, and
such cells show Ti, 3 rearrangements even more rarely than B cells; and nonhe-
matopoietic cells neither rearrange nor transcribe Ti, 3genes. This rule may apply
only to the initial step (D-j rearrangement) in Ti gene rearrangement; the tissue
specificity of later steps is probably more tightly controlled (27).
Because Northern blot hybridization measures the total accumulation of tran-
scripts in a population of cells, our data cannot distinguish between uniform low-
level Ti transcription, and high-level transcription by a small subpopulation of
cells. Either of these possibilities is consistent with the data and with the predic-
tions of the accessibility model. However, in the latter case one might expect to
see variations over time in the level of Ti gene transcription, due to possible
differential growth rates of Ti-transcribing and nontranscribing subclones. In
addition, according to the model, the Ti-transcribing cells might have a tendency
to rearrange their Ti genes. Since no significant variations in Ti mRNA levels
or Southern blot band patterns were observed over several months ofcell culture,
we believe this possibility is somewhat unlikely. The possibility of cell-to-cell
variation in Ti transcription levels within these B cell lines could be addressed
by analysis of several subclones of each line after limiting dilution.
Our data thus support the notion that transcription of unrearranged gene
segments is a consistent accompaniment, and perhaps a necessary prerequisite,
for gene rearrangement . Why then are truncated Ig and Ti transcripts synthe-
sized, albeit at low levels, in inappropriate cell types? We favor the idea that such
inappropriate transcripts and rearrangements do not have a direct functional
role, but rather reflect the inherent "leakiness" of the regulatory mechanisms
that govern antigen receptor gene rearrangement and expression . T and B
lymphocytes use very similar machinery for gene rearrangement, as evidenced
by the virtually identical heptamer-nanomer recombination signals used by Ti
and Ig genes, and by the ability of Abelson-transformed pre-B cells to rearrange
transfected Ti# genes (62). Furthermore, both T and B cells can use some cis-
acting Ig gene regulatory elements (63). Thus, it is not surprising that transcrip-
tion and rearrangement of Ti genes in B cells, and of Ig genes in T cells, do
occur. These events occur at levels low enough not to interfere with normal
lymphocyte function and the rearrangement of appropriate receptor genes (51) .
The study of these lineage-inappropriate transcripts may shed light on the
mechanisms of normal expression and rearrangement of antigen receptor genes.
Summary
We analyzed the transcription and rearrangement of the T cell antigen
receptor (Ti) genes Ti. and Tig in human B cell, T cell, and myeloid cell lines,
as well as in purified tonsillar B and T cells. All four B cell lines examined, as
well as one of two myeloid cell lines, expressed low levels of truncated Ti,g
transcripts, as did freshly purified tonsillar B cells. Two of the B cell lines and
one of the myeloid lines also expressed truncated Ti. transcripts, while tonsillar
B cells did not. Sequence analysis ofcDNA clones from a B cell line demonstrated
that these truncated Ti. and Ti, 3 transcripts were composed of unrearranged J195 4
￿
EXPRESSION OF T CELL RECEPTOR GENES IN HUMAN B CELLS
and C gene segments. Comparison of cDNA clones from T and B cells suggests
that D. genes or N regions contribute to the formation of Ti. transcripts in T
cells but not in B cells. None of the B cell or myeloid cell lines in this study
showed evidence of Tip gene rearrangements by Southern blotting. Our data,
and other studies of gene rearrangements in human tumors, demonstrate that
the level of Tip transcriptional activity and the frequency of Tip gene rearrange-
ments are correlated in all cell types examined. Thus, our data support the
accessibility model of antigen receptor gene rearrangement, whereby the suscep-
tibility of gene segments to recombination enzymes is correlated with their
transcriptional activity.
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